P-GLYCOPROTEIN INHIBITION EXACERBATES PACLITAXEL NEURONAL TOXICITY IN NEURONS AND CANCER PATIENTS.

被引：0
|
作者：
Stage, T. [1 ]
Khalaf, S. [1 ]
Steffensen, V. [1 ]
Hammer, H. [2 ]
Xiong, C. [3 ]
Nielsen, F. [1 ]
Poetz, O. [2 ]
Svenningsen, A. [1 ]
Rodriguez-Antona, C. [4 ]
Kroetz, D. [3 ]
机构：
[1] Univ Southern Denmark, Odense, Denmark
[2] Signatope, Reutlingen, Germany
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OIII-001
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [41] Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein
    Stordal, Britta
    Hamon, Marion
    McEneaney, Victoria
    Roche, Sandra
    Gillet, Jean-Pierre
    O'Leary, John J.
    Gottesman, Michael
    Clynes, Martin
    PLOS ONE, 2012, 7 (07):
  • [42] IS INHIBITION OF P-GLYCOPROTEIN (P-GP) SUBSTRATE DEPENDENT?
    Louie, Steven W.
    Hsiao, Peng
    Unadkat, Jashvant D.
    DRUG METABOLISM REVIEWS, 2014, 45 : 252 - 253
  • [43] Inhibition Mechanism of P-glycoprotein Mediated Efflux by mPEG-PLA and Influence of PLA Chain Length on P-glycoprotein Inhibition Activity
    Li, Wenjing
    Li, Xinru
    Gao, Yajie
    Zhou, Yanxia
    Ma, Shujin
    Zhao, Yong
    Li, Jinwen
    Liu, Yan
    Wang, Xinglin
    Yin, Dongdong
    MOLECULAR PHARMACEUTICS, 2014, 11 (01) : 71 - 80
  • [44] Loperamide and P-glycoprotein inhibition: assessment of the clinical relevance
    Vandenbossche, Joris
    Huisman, Maarten
    Xu, Yimei
    Sanderson-Bongiovanni, Dawn
    Soons, Paul
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (04) : 401 - 412
  • [45] Rapid assessment of P-glycoprotein inhibition and induction in vitro
    Perloff, MD
    Störmer, E
    von Moltke, LL
    Greenblatt, DJ
    PHARMACEUTICAL RESEARCH, 2003, 20 (08) : 1177 - 1183
  • [46] Inhibition of P-glycoprotein ATPase activity by beryllium fluoride
    Sankaran, B
    Bhagat, S
    Senior, AE
    BIOCHEMISTRY, 1997, 36 (22) : 6847 - 6853
  • [47] Inhibition of P-glycoprotein increases the uptake of paclitaxel into the brain, pre-clinical results and their translation to a clinical study
    Kemper, EM
    Boogerd, W
    Tjahja, IS
    Westerga, J
    Stokvis, E
    Schellens, JHM
    Beijnen, JH
    van Tellingen, O
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 108 - 109
  • [48] Rapid Assessment of P-Glycoprotein Inhibition and Induction in Vitro
    Michael D. Perloff
    Elke Störmer
    Lisa L. von Moltke
    David J. Greenblatt
    Pharmaceutical Research, 2003, 20 : 1177 - 1183
  • [49] Rational design of hybrid nanomicelles integrating mucosal penetration and P-glycoprotein inhibition for efficient oral delivery of paclitaxel
    Lian, He
    He, Zhonggui
    Meng, Zhaoxu
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2017, 155 : 429 - 439
  • [50] Novel pepper extract for enhanced P-glycoprotein inhibition
    Aher, Suyog
    Biradar, Shailesh
    Gopu, C. L.
    Paradkar, Anant
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (09) : 1179 - 1186
12345